Wallet Pharma Private Limited
About Wallet Pharma Private Limited
Data last updated:
Wallet Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India, a subsidiary of Hetero Labs Limited. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 07 December 2015 and has been in existence for over 11 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U24100TG2015PTC102108. Its GSTIN is 36AABCW7390K1ZS (Telangana).
The company has an authorised share capital of ₹100 Cr and a paid-up capital of ₹98 Cr. It is led by directors Chittajallu Gopalakrishna and Palleswara Rao Palapatla Govada.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹4.67 Cr, a growth of 83% compared to the previous year. For the same year it recorded a net profit of ₹1.63 Cr (net margin 34.9%) and EBITDA of ₹2.25 Cr (EBITDA margin 48.2%). Revenue has grown at a compounded annual rate (CAGR) of 101% over three years and 2% over five years.
The company has 5 deals on record (4 funding rounds, 1 secondary share transfer), with disclosed funding of ₹97.99 Cr; the latest was in March 2021. Its 10 peer companies in the Pharma industry (Pharma Retail and Distribution) are compared by revenue, 5 larger and 5 smaller; the largest is Aarkem Healthcare Private Limited with revenue of ₹4.68 Cr.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressDmr Corporate Plot No. 201 & 202, 3rd Floor Kavuri Hills Madhapur, Hyderabad, Telangana, India – 500033
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Wallet Pharma Private Limited
The main business activity of Wallet Pharma is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Wallet Pharma Private Limited FY 2025 filings available
Wallet Pharma Private Limited reported revenue of ₹4.67 Cr (up 83% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Wallet Pharma Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 2% over five years, including 83% growth in the latest year. EBITDA fell 9% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Wallet Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.25 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹1.63 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Wallet Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 48.2% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 34.9% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Wallet Pharma are in the company report.
Financial statements from FY 2016
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Wallet Pharma Private Limited
Wallet Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Aarkem Healthcare Private Limited | ₹4.68 Cr (FY 2025) | •••• | •••• | 228.0% | •••• | Tijara, Rajasthan, India |
| Bis Marck Pharmaceuticals Private Limited | ₹4.68 Cr (FY 2025) | •••• | •••• | 28.0% | •••• | Rajkot, Gujarat, India |
| Lakshmi Narsimha Diagnostics & Healthcare Private Limited | ₹4.67 Cr (FY 2025) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Batra Businesses Private Limited | ₹4.67 Cr (FY 2025) | •••• | •••• | 47.0% | •••• | Jaipur, Rajasthan, India |
| Mint Pharmaceuticals Private Limited | ₹4.67 Cr (FY 2024) | •••• | •••• | -5.0% | •••• | Chennai, Tamil Nadu, India |
| Wallet Pharma Private Limited this company | ₹4.67 Cr (FY 2025) | •••• | •••• | 83.0% | •••• | Hyderabad, Telangana, India |
| Kale Pharma Private Limited | ₹4.67 Cr (FY 2025) | •••• | •••• | 3.0% | •••• | Pune, Maharashtra, India |
| Dua Health Care Private Limited | ₹4.67 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Delhi, India |
| Exgen Care Private Limited | ₹4.67 Cr (FY 2024) | •••• | •••• | 71.0% | •••• | Noida, Uttar Pradesh, India |
| Avian Life Sciences Private Limited | ₹4.66 Cr (FY 2025) | •••• | •••• | 6.0% | •••• | Hyderabad, Telangana, India |
| Biocyte Organics Private Limited | ₹4.66 Cr (FY 2024) | •••• | •••• | 45.0% | •••• | Kanpur, Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Wallet Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Wallet Pharma Private Limited
Wallet Pharma Private Limited is audited by M V NARAYANA REDDY & CO for the financial year 2020.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| M V NARAYANA REDDY & CO | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Wallet Pharma Private Limited
Wallet Pharma has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Chittajallu Gopalakrishna Also directs: Anaika Industries Limited, Actero Pharma Private Limited, Abhiru Industries Limited and 1 more | Director | 20 Jun 2017 | 9 Years 3 Months | Current |
| Palleswara Rao Palapatla Govada Also directs: Annora Pharma Private Limited | Director | 07 Dec 2015 | 10 Years 10 Months | Current |
Ownership and Shareholding of Wallet Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Wallet Pharma Private Limited
Wallet Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Deals & Funding of Wallet Pharma Private Limited
Wallet Pharma Private Limited has 5 deals on record (4 funding rounds, 1 secondary share transfer), with disclosed funding of ₹97.99 Cr; the latest was in March 2021.
Deals on record (5 of 5)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2021 | Funding round | ₹64 Cr | Investors: Hetero Drugs Limited |
| Mar 2021 | Secondary share transfer | Undisclosed | Buyer: Viraji Pharma Private Limited & Bandi Kalavathi, Viraji Pharma Private Limited Seller: Hetero Drugs Limited , Hetero Labs Limited & K. Rathnakar Reddy |
| Dec 2019 | Funding round | ₹11.05 Cr | Investors: Hetero Drugs Limited |
| Mar 2018 | Funding round | ₹21.75 Cr | Investors: Hetero Drugs Limited |
| Sep 2016 | Funding round | ₹1.19 Cr | Investors: Hetero Drugs Limited |
Full deal history
All 5 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Employees and EPFO Compliance at Wallet Pharma Private Limited
Employment history and EPFO contributions of people linked to Wallet Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Wallet Pharma Private Limited
Wallet Pharma Private Limited has 4 board changes on record since 2015: 2 appointments and 2 cessations. The latest: Chandra Sekhar Tumuluru ceased to be Director on 01 Nov 2023.
Credit Ratings, Litigation & Regulatory Alerts for Wallet Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Wallet Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Wallet Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Wallet Pharma Private Limited
Wallet Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AABCW7390K1ZS | Telangana | Active | 01 Jul 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Wallet Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Wallet Pharma Private Limited
Wallet Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 07 December 2015 (11+ years old) and is registered under CIN U24100TG2015PTC102108.
Wallet Pharma reported revenue of ₹4.67 Cr for FY 2025 (up 83% YoY).
Wallet Pharma has 2 current directors:
- Chittajallu Gopalakrishna - Director
- Palleswara Rao Palapatla Govada - Director
Wallet Pharma reported a net profit of ₹1.63 Cr (net margin 34.9%) and EBITDA of ₹2.25 Cr (EBITDA margin 48.2%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Wallet Pharma is 101% over three years and 2% over five years. In the latest year (FY 2025) revenue rose 83%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Wallet Pharma is 36AABCW7390K1ZS, registered in Telangana.
The CIN (Corporate Identification Number) of Wallet Pharma is U24100TG2015PTC102108. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Wallet Pharma was incorporated on 07 December 2015, making it 11+ years old. It is registered with the Registrar of Companies, Hyderabad.
Wallet Pharma has 5 deals on record (4 funding rounds, 1 secondary share transfer), with disclosed funding of ₹97.99 Cr; the latest was in March 2021.
The peers of Wallet Pharma by revenue are Aarkem Healthcare Private Limited, Bis Marck Pharmaceuticals Private Limited, Lakshmi Narsimha Diagnostics & Healthcare Private Limited, Batra Businesses Private Limited, Mint Pharmaceuticals Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Chandra Sekhar Tumuluru ceased to be Director on 01 Nov 2023. Chittajallu Gopalakrishna ceased to be Additional Director on 08 Sep 2017. Chittajallu Gopalakrishna was appointed as Director on 20 Jun 2017. Wallet Pharma has 4 board changes on record in total.